Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.5.3 was added to the study page history, replacing the previous revision v3.5.2. This indicates a minor update to the page record without changes to the study content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.5.2 is now shown on the page; the previous label v3.5.0 has been removed.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.5.0 is listed as the current version, replacing v3.4.3.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check89 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing v3.4.1. No study content or page functionality appears to be affected.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page adds Revision: v3.4.1 and removes the earlier entries Revision: v3.4.0 and the government funding/operating-status notice.SummaryDifference0.4%

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.